If you are a life science professional and would like to know more about atherosclerosis or the technology behind our products, you will find much more detail in the scholarly publications written by CardioVax collaborators and leading experts in atherosclerosis:


About Atherosclerosis

The Immune Response in Atherosclerosis: A Double-Edged Sword

–Goran K. Hansson and Peter Libby


About The Injectable Vaccine

CD8+ T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide

–Kuang-Yuh Chyu., Xiaoning Zhao., Paul C. Dimayuga, Jianchang Zhou, Xiaojun Li, Juliana Yano, Wai Man Lio, Lai Fan Chan, Jonathan Kirzner, Portia Trinidad, Bojan Cercek, Prediman K. Shah


About The Mucosal Vaccine

Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis

–Roland Klingenberg, Michael Lebens, Andreas Hermansson, Gunilla Nordin Fredrikson, Daniela Strodthoff, Mats Rudling, Daniel F.J. Ketelhuth, Norbert Gerdes, Jan Holmgren, Jan Nilsson and Goran K. Hansson


About The Autologous Cellular Immunotherapy

Immunotherapy With Tolerogenic Apolipoprotein B-100-Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice

–Andreas Hermansson, Daniel K. Johansson, Daniel F.J. Ketelhuth, John Andersson, Xinghua Zhou and Göran K. Hansson


CV Logo Footer

10100 Santa Monica Blvd., Suite 925

Los Angeles, CA 90067 United States

Tel.: 424. 263. 6364